+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation



Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation



Journal of Urology 179(6): 2364-7; Discussion 2367-8



Endoscopic implantation of dextranomer/hyaluronic acid has proved to be an effective minimally invasive technique for correcting vesicoureteral reflux in children. There is some evidence suggesting that in addition to being less invasive, successful dextranomer/hyaluronic acid implantation compared to successful antireflux surgery is associated with fewer febrile and nonfebrile urinary tract infections. We review the clinical outcomes of 2 groups of children cured of reflux with open surgery and dextranomer/hyaluronic acid implantation to determine if a difference in clinical outcomes exists. We reviewed the charts of 43 patients who underwent dextranomer/hyaluronic acid implantation and 33 who underwent open surgery for vesicoureteral reflux. Data collected included age, gender, preoperative and postoperative grades of reflux, and urinalysis and urine culture results. Urinary tract infection was defined as any culture that grew more than 10(5) colonies of a single organism, with symptoms typical of cystitis (urgency, frequency, dysuria). A febrile urinary tract infection was defined as an infection accompanied by a temperature greater than 101.5F. Any hospitalizations for febrile episodes were also recorded. The incidence of urinary tract infection after successful open surgery (38%) was significantly higher than that observed following successful dextranomer/hyaluronic acid treatment (15%, p = 0.03). Febrile urinary tract infections occurred in 24% of the children who underwent open surgery and in 5% of those who underwent dextranomer/hyaluronic acid implantation (p = 0.02). Hospital readmissions occurred only in the group undergoing open surgery. Children successfully cured of vesicoureteral reflux with dextranomer/hyaluronic acid implantation have a lower incidence of febrile and nonfebrile urinary tract infections compared to those cured with open surgery. These findings suggest that dextranomer/hyaluronic acid implantation, when successful, may result in more favorable clinical outcomes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 031879428

Download citation: RISBibTeXText

PMID: 18436248

DOI: 10.1016/j.juro.2008.01.149


Related references

Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long-term results. Journal of Pediatric Urology 9(4): 483-487, 2013

Re: randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long-term results. Journal of Urology 191(5): 1407-1407, 2014

Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid. Journal of Urology 180(4 Suppl): 1605-9; Discussion 1610, 2008

Salvage ureteral reimplantation after failure of dextranomer/hyaluronic acid injection. Journal of Urology 186(1): 257-260, 2011

Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. Journal of Urology 182(4 Suppl): 1708-1712, 2009

Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. Journal of Urology 179(5): 1966-1969, 2008

Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates. Journal of Urology 185(6 Suppl): 2531-2534, 2011

Endoscopic hyaluronic acid/dextranomer gel implantation is effective as first-line treatment of vesicoureteral reflux (VUR) in children: a single centre experience. European Journal of Pediatric Surgery 21(5): 299-303, 2012

Re: delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (deflux) injection for treatment of vesicoureteral reflux in children: a case series. Journal of Urology 191(5): 1409-1409, 2014

Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series. Urology 81(3): 659-662, 2013

Endoscopic injection of bulking agents in children with incontinence: dextranomer/hyaluronic acid copolymer versus polytetrafluoroethylene. Journal of Urology 178(4 Pt 2): 1628-1631, 2007

Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?. Journal of Urology 189(1): 275-282, 2013

Endoscopic injection of dextranomer/hyaluronic acid for vesico-ureteral reflux--preliminary results. Harefuah 144(9): 613, 2005